EP1977787A1 - Système d'impulsion magnétique pour induire les courants électriques dans un corps humain - Google Patents

Système d'impulsion magnétique pour induire les courants électriques dans un corps humain Download PDF

Info

Publication number
EP1977787A1
EP1977787A1 EP07251460A EP07251460A EP1977787A1 EP 1977787 A1 EP1977787 A1 EP 1977787A1 EP 07251460 A EP07251460 A EP 07251460A EP 07251460 A EP07251460 A EP 07251460A EP 1977787 A1 EP1977787 A1 EP 1977787A1
Authority
EP
European Patent Office
Prior art keywords
magnetic
patient
pulser system
capacitors
pulses
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP07251460A
Other languages
German (de)
English (en)
Other versions
EP1977787B1 (fr
Inventor
Robert E. Fischell
Scott J. S. Fischell
David R. Fischell
Emily Ma
Kuen Chang
Dave Vondle
Benjamin Pless
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Neuralieve Inc
Original Assignee
Neuralieve Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neuralieve Inc filed Critical Neuralieve Inc
Priority to DE602007004301T priority Critical patent/DE602007004301D1/de
Priority to AT07251460T priority patent/ATE454923T1/de
Priority to EP07251460A priority patent/EP1977787B1/fr
Priority to ES07251460T priority patent/ES2338379T3/es
Publication of EP1977787A1 publication Critical patent/EP1977787A1/fr
Application granted granted Critical
Publication of EP1977787B1 publication Critical patent/EP1977787B1/fr
Not-in-force legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N2/00—Magnetotherapy
    • A61N2/004—Magnetotherapy specially adapted for a specific therapy
    • A61N2/008—Magnetotherapy specially adapted for a specific therapy for pain treatment or analgesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N2/00—Magnetotherapy
    • A61N2/02—Magnetotherapy using magnetic fields produced by coils, including single turn loops or electromagnets

Definitions

  • This invention is in the field of methods and devices for the treatment of certain human disorders, particularly for the treatment of diseases of the brain.
  • migraine headaches occur in approximately 12% of the world population. Therefore, in the United States in the year 2005 there are approximately 30 million people who suffer from this affliction. Although medicines have been created that significantly diminish the suffering of migraine patients, these medicines are often contraindicated and have highly undesirable side effects and many patients do not obtain satisfactory relief from the severe headache pain, nausea and other discomforts associated with migraine. Furthermore, migraine headaches are typically treated after they have become painful, i.e., the treatment is often ineffective in preventing the onset of the migraine headache. Other than some drugs that are efficacious for some patients, there is currently no known treatment for migraine headaches that can be applied after a patient detects an aura of that headache to prevent the occurrence of pain and other undesirable manifestations of that migraine headache. A non-invasive, non-drug method for preventing the occurrence of migraine headaches would be a remarkable boon for those millions of people all over the world who suffer from these painful and often debilitating experiences.
  • TMS Transcranial Magnetic Stimulation
  • Robert E. Fischell et al describe means and methods for the treatment of migraine headaches using a portable device that is placed onto the patient's head.
  • This device is used to create a magnetic pulse that acts upon the neurons of the brain and can eliminate both the aura that occurs prior to a migraine headache and a migraine headache after it has started.
  • the entire device is placed onto the patient's head, it is somewhat awkward for the patient's use.
  • the triggering controls are also located on the head mounted device, their operation is also somewhat difficult.
  • An embodiment of the invention can provide a means and method for improving the treatment of any number of disorders of the brain that can be treated by creating electric currents in the brain by the application of a high intensity, short duration magnetic pulse or a series of such pulses.
  • An example of such diseases includes all types of headaches, depression, obsessive-compulsive disorder, insomnia, bipolar disease, epileptic or febrile seizures and status epilepticus.
  • an intense, short duration, magnetic pulse or a collection of pulses could be applied as therapy by stimulation of a variety of nerves such as the occipital nerve or the trigeminal nerve in the region of the head and the vagal nerve in the region of the neck.
  • magnetic pulses applied to the carotid sinus and/or vagal nerve in the neck can be used to stop an episode of atrial fibrillation.
  • TMS pulses for the treatment of migraine headache
  • system used for the treatment of migraine headache could also be used for the treatment of other disorders such as those mentioned herein.
  • multiple magnetic pulses could be used instead of a single pulse. These multiple pulses could either be a multiplicity of single pulses that are spaced apart by a few seconds to several minutes, or they could be rTMS which is a continuous train of magnetic pulses.
  • the patient will be described in this specification as being of the female gender, it should be understood that the invention can be used by either males or females and by children or adults.
  • An embodiment of the invention can be a single unit, portable magnetic pulser that can be placed by the patient onto any region which is in contact with or placed near her head.
  • the pulser can be powered by a battery, from a wall receptacle or from an automobile's lighter receptacle. After the pulser is plugged into a power source, a charge switch can be pressed by the patient to begin charging the capacitors to a comparatively high voltage.
  • a visual display would clearly indicate that the capacitors are charging.
  • a line of LEDs would turn on from one end to the other indicating the progression of the charging cycle.
  • the TMS pulser could employ a linear bar that progressively fills with light as the capacitors are charged.
  • a visual indicator such as a lit green LED, would show that the capacitors are now ready to be discharged into a low resistance coil to produce a high intensity, short duration, magnetic pulse.
  • the visual display used would be of a color and intensity (e. g., a dim blue light) that would be minimally disturbing to any person having a migraine headache. Examples of such visual displays include a series of LEDs or an LCD display (monochrome or color).
  • the charge switch could be under a cover, be a slide or rotary switch, require activation for a fixed period of time or any other technique that provides a means to prevent inadvertent charging. If the charge switch is accidentally pressed, disconnecting the source of electric power will prevent the capacitors from becoming fully charged.
  • the button to discharge the capacitors into the magnetic coil she would have placed the bottom surface of the pulser against her head or any other region of her body where the magnetic pulse would be therapeutic.
  • the high intensity, short duration, magnetic pulse would, by Faraday's Law, create electric currents in the neurons of the brain (or elsewhere in the body) that would be a treatment for the patient's disorder. For example, if the magnetic pulse was applied to the occipital lobe of the brain during the visual aura before a migraine headache, the aura could be substantially erased and the patient would not progress to having a migraine headache.
  • the magnetic pulse applied to another region of the body could be used to generate an electric current pulse at that location, which electric current pulse could be therapeutic.
  • TMS pulser An important factor in the design of the TMS pulser is its ability to limit the number of pulses that the patient could apply to her brain without authorization from the physician who prescribed the device for the patient's use. If there were an unlimited number of pulses that the device could deliver, a patient might allow an unauthorized person to use the device without a proper prescription from a doctor. By limiting the number of pulses that could be applied without a refill prescription from the patient's doctor and by charging a moderate amount of money for each pulse that is used, the patient will not be tempted to allow others to use her pulser. It should however be understood that a device which can apply an unrestricted number of pulses is conceived of as included in the concept of the present invention.
  • a potential safety aspect of an embodiment of the invention is that the TMS pulser could limit the number of pulses per unit time that the patient could receive.
  • the device could be designed to disallow more than (let us say) ten pulses in any one hour period.
  • the pulser could include a standard RJ-11 telephone jack that the patient could use to allow the device manufacturer to add pulses over a telephone connection as allowed by a refill prescription from the patient's doctor.
  • the telephone connection could be used to transmit date and time stamped pulse usage from the TMS pulser to the patient's doctor or a central diagnostic center for patient monitoring.
  • the telephone connection could also provide device diagnostics if the pulser was not operating properly.
  • An alternative means for providing additional pulses and reading data into and out of the pulser would be by means of a USB key or any other device that would connect to a standard type of computer input connection such as an Ethernet connection. When inserted into the pulser, the USB key could be used to increase the number of allowed pulses.
  • any refill of pulses would have to be authorized by a valid and current refill prescription from the patient's doctor.
  • the USB key would typically be a standard USB thumb drive with encoded data that will instruct the TMS pulser to allow a prescribed number of allowed pulses.
  • the TMS pulser would be designed so that the USB key would only enable additional pulses once as removing and reinserting the USB key a second time would have not add additional pulses.
  • an LCD, LED (or other) display could be provided that indicates the number of pulses remaining. If the number of available pulses dropped to that number that would be used by the patient in only a few days, the patient could ask the doctor for a refill prescription or the refill prescription could be on file with the organization that provides a variety of patient services. The patient could then receive a refill from the patient services organization through the telephone connection or by means of the USB key.
  • a refill could be accomplished by the use of the USB slot in a personal computer that is connected over the Internet to the TMS pulser manufacturer (or an authorized service organization) who could verify the refill prescription and the source for payment for the pulses and send the properly encoded data to the USB key to permit additional pulses. The patient would then remove the updated USB Key and insert it into the TMS pulser.
  • USB key could be sent by mail or purchased at the patient's local pharmacy. It should also be understood that a date and time stamped history of the number of pulses used could be made available to the doctor or the manufacturer by means of the telephone connection or the USB port from data stored in a digital memory in the pulser.
  • the USB port would work by either connecting using a cable to a PC or by transferring the data to the USB key which is then inserted in a the USB slot of a computer connected to the Internet.
  • the magnetic pulser system could include a self-checking means that would verify that the magnetic pulse was within a specified limit of amplitude and time duration. This could be accomplished by a separate wire coil located near the device's magnetic coil that would measure the amplitude and time course of the magnetic pulse. If either the amplitude or time course of the magnetic pulse were out of their specified limits, the magnetic pulser system could produce an error signal that would be detected by the patient and could also be determined by a patient's service center via a telephone or Internet connection. The warning could be by means of a visual display or by means of a voice warning. Additionally, the patient could be provided with a separate device that could be used to check the amplitude and time course of the magnetic pulse.
  • each pulser can have a unique serial number that is recorded for a particular patient.
  • the TMS pulser transmits the stored data on pulse usage or receives instructions to add pulses
  • the data transmitted to and from the TMS pulser must be encrypted so that it would be essentially impossible for an unauthorized person to add pulses to the pulser or to gain access to the patient's use of pulses to treat her brain (or other) disorder.
  • a secure link could allow the patient to be recognized only by her serial number so that her actual name would not be known to the operator at the manufacturer's service center. Thus patient confidentiality would be maintained.
  • J. A. Cadwell describes a magnetic coil that has the shape of a skull cap. Although this design can function to provide a TMS pulse, an embodiment of the invention can provide an improved coil design which can be in the form of a racetrack, a invention describes an improved coil design which can be in the form of a racetrack, a true ellipse or a quasi-elliptically shaped coil. Any of these shapes of a coil that is generally longer in one direction compared to the length at a right angle to the coil's long axis will be described herein as being elliptical in shape. The elliptical coil would be curved around its short axis to generally suit the curvature of a human head.
  • the curved, elliptical shape for a TMS magnetic coil allows both the left and right occipital lobes to be stimulated at the same time.
  • the patient would merely have to center the long axis of the coil over the centerline of occipital lobe of the head and she would then erase the aura irrespective of which side of the occipital lobe was the source of that visual aura.
  • TMS systems that have been used for many years for brain research purposes are capable of creating a magnetic pulse that could usefully be used for therapeutic purposes
  • all prior TMS systems have been very large and weigh over 50 pounds. Therefore, they are not really portable for a typical patient. Furthermore, these systems are never operated by the patient but rather they are operated by the medical personnel who are performing the brain research experiment.
  • One embodiment of the invention can provide a truly portable device that could be carried in at least a large pocketbook of a woman patient.
  • An embodiment of the invention can provide a portable magnetic pulser system to be a TMS device that is operated by the patient and weighs less than 10 pounds. Optimally the pulser weighs less than 4 pounds.
  • An embodiment of the invention can provide a magnetic pulser that is portable and operated by the patient for the treatment of disorders of the brain or other human organs, the magnetic pulser being designed to provide one or more, high intensity, short duration, magnetic pulse that is applied to the neurons of the brain or to any other body part that is to be treated.
  • An embodiment of the invention can limit the total number of pulses available before a refill takes place and also to limit the number of pulses allowed in a predefined time period.
  • An embodiment of the invention can have the availability of additional magnetic pulses provided by means of a telephone (or Internet) connection or from a USB key from an authorized provider of the pulses and based upon a refill prescription from the patient's doctor.
  • An embodiment of the invention can have the refill data message in an encrypted format so that a refill of pulses cannot be accomplished without proper authorization.
  • An embodiment of the invention can have a curved, elliptically-shaped coil for the pulser that can create a magnetic pulse over either or both sides of the occipital lobe of the brain.
  • An embodiment of the invention can have a visual display on a TMS pulser that can show the number of pulses remaining, the status of the charging cycle and that the capacitors are fully charged.
  • An embodiment of the invention can have a means to prevent inadvertent activation of the charge switch which starts the capacitor charging cycle.
  • An embodiment of the invention can have the visual displays be designed to minimize discomfort for a person experiencing a migraine headache.
  • FIGS. 1, 2 and 3 are respectively the side view, end view and top view of an example of a magnetic pulser 10. These FIGS. 1, 2 and 3 show the electronics system 20 joined to the magnetic coil section 40 by the connecting structure 30. FIGS. 1, 2 and 3 show the information and control display panel 21 that includes a charge switch 22, a pulse button 23, a ready light 24, a charging indicator bar 27 and a number of pulses remaining display 28. FIG. 3 shows that the number of pulses remaining is 39. When the plug 51 of the power cord 50 (of FIG. 3 ) is plugged into the power receptacle 25, the number of pulses remaining display is illuminated. This immediately tells the patient that the magnetic pulser 10 is powered.
  • an ON-OFF switch (not shown) would or could be utilized.
  • the patient can press the charge switch 22 which causes the capacitors 31 (as seen in FIGS. 4 and 6 ) to begin to charge.
  • the extent to which the capacitors 31 are charged is shown by the charging indicator bar 27.
  • a sequence of individual lights could also be used to indicate that the capacitors 31 are being charged.
  • the bar 27 is fully illuminated and the ready light 24 turns on.
  • the patient can place the curved surface 41 of the magnetic coil section 40 against her head and then press the pulse button 23 which will discharge the capacitors 31 into the magnetic coil 42 (shown in FIGS. 5 and 6 ).
  • the charge switch 22 could be under a cover, be a slide or rotary switch, require activation for a fixed period of time or any other technique that provides a means to prevent inadvertent charging.
  • FIG. 3 shows one form of a power cord 50, namely the type that would be plugged into a typical household receptacle.
  • This power cord 50 has a plug 51 that is electrically connected to a transformer-rectifier 52 by means of wires 53.
  • the transformer-rectifier 52 would have two or three prongs to be plugged into the household receptacle that is typically 115 volts AC in the USA. It is also conceived that a different type of power cord could be plugged into a conventional cigarette lighter (or other power source) in an automobile. In any case, it would be typical that the voltage at the plug 51 would be 12 volts DC.
  • a power cord could be joined to a battery that had either primary cells or rechargeable cells either of which could be used to power the magnetic pulser 10. It is further understood that the magnetic pulser 10 could have a self-contained battery that was either rechargeable or used replaceable cells.
  • FIGS. 1, 2 and 3 also show a receptacle access wall 18 into which the power receptacle 25 and a USB key receptacle 26 could be placed.
  • the USB key receptacle 26 would be used with a USB key 60 of FIG. 3 as will be explained below with the assistance of FIG. 6 .
  • FIG. 4 is a partial cross section of the magnetic pulser 10 showing a cross section of the display panel 21 that includes the charge switch 22, the pulse button 23 and the ready light 24.
  • FIG. 4 also shows the receptacle access wall 18, the connecting structure 30 and the magnetic coil section 40.
  • One or more capacitors 31 are shown within the connecting section 30.
  • the electronics module 29 is shown within the electronics section 20. The components within the electronics module 29 will be described below with the assistance of FIG. 6 .
  • FIG. 5 is a cross section of the magnetic pulser 10 showing the connecting structure 30 as it is joined to the magnetic coil section 40.
  • the plastic molded wall 31 is formed generally around the entire magnetic pulser 10.
  • the curved surface 41 of the magnetic coil section 40 is designed to be approximately the same curvature as a human head. An exact match to the curvature of any particular head is not required for the therapeutic effect to be achieved. A curvature for the surface 41 having a radius that is greater than 3 inches and less than 6 inches would be acceptable for the magnetic pulser system 10. A radius of curvature of approximately 4.5 inches would be satisfactory for most patients. It is conceived that the exact curvature for any patient could be approximately matched to the curvature of her specific head. For example, it is conceived that the manufacturer could make three different curvatures for heads having either a small, medium or above average curvature.
  • FIG. 5 also shows the general arrangement of the electrical wire that forms the magnetic coil 42.
  • FIG: 5 shows the electrical wire to be solid metal (which could have an insulating covering) with a conventional circular cross section
  • an improved design would be Litz wire that includes many strands that are each insulated from the other strands of the wire.
  • Another good cross section for the wire would be rectangular with a very thin dimension (0.001 to 0.1 inches) in one direction and a dimension between 0.2 and 0.8 inches in the orthogonal dimension.
  • An optimum design would be Litz wire having a square cross section of the collected strands.
  • copper would be an adequate metal from which the magnetic coil 42 could be made, pure aluminum wire would have the advantage of being considerably lighter.
  • the optimum wire for the magnetic coil 42 would probably be aluminum Litz wire that has a square or rectangular cross section.
  • FIG. 5 also shows a single magnetic lamination 43 which is formed to the shape of the magnetic coil 42. Although only one lamination is shown, it is conceived that a multiplicity of magnetic laminations could be used to increase the magnetic field strength in the direction of the head while decreasing the magnetic field intensity in the direction of the connecting structure 30.
  • the ferromagnetic material from which the lamination(s) 43 could be made include silicon iron or any other magnetic material that has a comparatively high permeability and saturation flux density.
  • FIG. 6 is a block diagram of the magnetic pulser system 10.
  • the power receptacle 25 (from an outside power source) energizes a DC to DC converter 71 (or an AC to DC inverter that is not shown) to provide the appropriate power for all of the electronics shown in FIG. 6 .
  • the output of the converter 71 goes to the control circuit 70 which controls the charging and discharging of the capacitors 31.
  • a high voltage line (typically between 300 and 800 volts) is used to charge the capacitors 31. Although a single high voltage capacitor might be used, a combination of at least two capacitors in series or in parallel is often more advantageous.
  • the magnetic pulser system 10 is controlled by the central processing unit (CPU 79) which follows the instructions stored in the memory 75.
  • CPU 79 central processing unit
  • the CPU 70 When power is applied to the power receptacle, the CPU 70 will boot-up from the memory 75 and the power on light 86 will light. Instead of a power on light, the number on the remaining pulses 29 could illuminate to indicate that the power is on.
  • the CPU 79 will also enable the appropriate number to be shown on the remaining pulses display 29.
  • the memory 75 should include at least a portion of non-volatile memory so that the remaining number of pulses and patient data will be retained when the system 10 is unplugged from a power source or turned off.
  • the system 10 is ready to be used. Assuming there are remaining pulses, the patient would activate the charge switch 22 which would cause the CPU 79 to activate the control circuit 70 to begin charging the capacitors 31. As the capacitors 31 are charging, the control circuit 70 monitors the voltage and communicates this information to the CPU 79 which activates the charging indicator bar 27 which is typically a continuously illuminated bar, or alternatively, a linear array of LEDs where first one LED is lit, then two, then three and so on until the entire array is lit as the capacitors 31 reach their full charge. When the capacitors 31 are fully charged, the CPU 79 will activate the ready light 24 which is typically green. The patient would then place the surface 41 of FIG.
  • a preferred embodiment of the pulse button 23 integrates the ready light 24 into the button 23.
  • the ready light 24 goes off, the illuminated bar on the charging indicator bar 27 turns off and the remaining pulse display 29 will show one less pulse.
  • An additional feature of the electrical circuitry of the magnetic pulser system 10 is that when the ready light comes on, the audio circuitry 74 could provide an audio signal (that is a verbal signal) through the speaker 73 which indicates to the patient that the magnetic pulser system 10 is ready to provide a magnetic pulse. When the pulse is completed, the audio circuitry 74 through the speaker 73 could also state that the pulse has been delivered. Additional audio signals could provide other messages such as there is an error and the device is not functioning or the voltage is too low, or there are only a limited number of pulses remaining, etc. In whatever country the device is sold, the audio signal could be in the language of that country or even in the language or dialect of a limited region of a country.
  • a USB key 60 when inserted in to the USB port 26 could be used to increase the number of pulses remaining by a specific number as specified in the doctor's refill prescription and as paid for by the patient. For example, a refill accomplished by the USB key could be for 25, 50 or 100 additional pulses.
  • the CPU 79 and memory 75 could also hold an encrypted security code that disallows any input for additional pulses that is not provided by the manufacturer's service center.
  • the memory 75 could store the date and time for each pulse that is delivered by the TMS pulser system 10. The time history of the patient's use of pulses can be stored in the memory 75 and could be read out through the data communication circuitry 73 through the USB port 26, the Ethernet jack 82 or the RJ-11 telephone jack 84.
  • a small magnetic field detection coil 76 would be placed in close proximity to the magnetic coil 42.
  • the coil 76 would feed into the pulse measurement circuitry 77 that would tell the CPU 79 to illuminate an error signal light (not shown) on the magnetic pulser system 10 if the amplitude and/or duration of the magnetic pulse was out of a pre-specified range.
  • the letters "E” or "ER” could also appear on the pulse counter to indicate that an incorrect pulse was generated.
  • the patient may also be warned that the pulse was out of its specified limits by means of the audio circuitry 74 and the speaker 73.
  • USB port 26 By means of the USB port 26 or a data communications connection through the Ethernet jack 82 or RJ-11 telephone jack 84, a technician at the patient's service center could determine if the magnetic pulse was within its specification and also the exact time history of each magnetic pulse. Thus each device in the patient's hands could be checked to see that it was performing properly. To avoid tampering, it is envisioned that the opening of the case would result in the magnetic pulse system 10 becoming completely inoperative. This could be through erasure of the boot instructions in the memory 71 or through other means.
  • FIG. 7 shows a typical magnetic pulse that can be created when the capacitors 31 are discharged into the magnetic coil 42.
  • the peak magnetic field of about 1.0 ⁇ 0.5 Tesla would be created at the center of the bottom surface of the magnetic coil 42.
  • the time to reach the pulse's maximum field strength should ideally be 175 ⁇ 100 microseconds, although the time to maximum pulse strength could vary from as little as 10 microseconds to as long as 10,000 microseconds. What is most important is that the time rate of change of the magnetic pulse be fast enough to create a therapeutic electric current in the brain or other human tissue.
  • the maximum value of the strength of the magnetic field within the brain should be at least 0.05 Tesla. If the maximum value of the field within the brain is less than 0.05 Tesla, the magnetic pulser system 10 will not function for many patients.
  • the acceptable range for the maximum value of the magnetic field within the patient's brain should lie between 0.05 and 5.0 Tesla.
  • the optimum range for the maximum magnetic field strength onto some part of the patient's brain should lie between 0.2 and 1.0 Tesla.
  • an effective magnetic pulser system 10 could be created that utilizes some but not all of the features as described herein.
  • a magnetic pulser system could be created and work effectively without a pulse counting feature.
  • Another example are the audio signals for the patient which could also be eliminated and still an effective magnetic pulser system could function for the treatment of migraine headache and other disorders.
  • These are just two examples of the several that could be eliminated and the magnetic pulser system 10 would still be of value for most patients.
  • the use of the word "capacitors" has the meaning of one or more capacitors.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Radiology & Medical Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Chemistry (AREA)
  • Magnetic Treatment Devices (AREA)
EP07251460A 2007-04-02 2007-04-02 Système d'impulsion magnétique pour induire les courants électriques dans un corps humain Not-in-force EP1977787B1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
DE602007004301T DE602007004301D1 (de) 2007-04-02 2007-04-02 Magnetisches Pulssystem zur Leitung elektrischer Ströme in einen menschlichen Körper
AT07251460T ATE454923T1 (de) 2007-04-02 2007-04-02 Magnetisches pulssystem zur leitung elektrischer ströme in einen menschlichen körper
EP07251460A EP1977787B1 (fr) 2007-04-02 2007-04-02 Système d'impulsion magnétique pour induire les courants électriques dans un corps humain
ES07251460T ES2338379T3 (es) 2007-04-02 2007-04-02 Sistema de impulsos magneticos para inducir corrientes electricas en un cuerpo humano.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07251460A EP1977787B1 (fr) 2007-04-02 2007-04-02 Système d'impulsion magnétique pour induire les courants électriques dans un corps humain

Publications (2)

Publication Number Publication Date
EP1977787A1 true EP1977787A1 (fr) 2008-10-08
EP1977787B1 EP1977787B1 (fr) 2010-01-13

Family

ID=38226374

Family Applications (1)

Application Number Title Priority Date Filing Date
EP07251460A Not-in-force EP1977787B1 (fr) 2007-04-02 2007-04-02 Système d'impulsion magnétique pour induire les courants électriques dans un corps humain

Country Status (4)

Country Link
EP (1) EP1977787B1 (fr)
AT (1) ATE454923T1 (fr)
DE (1) DE602007004301D1 (fr)
ES (1) ES2338379T3 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2373369A1 (fr) * 2008-11-21 2011-10-12 Burkhard Brocke Dispositif mobile d autostimulation transcrânienne et procédé de commande et de régulation du dispositif
US8911342B2 (en) 2009-06-22 2014-12-16 Re5 Aps Apparatus and method for pulsed electrical field treatment
EP2403586A4 (fr) * 2009-03-06 2017-04-26 Neuralieve, Inc. Procédé et appareil d'enregistrement et d'analyse pour traitements par tms et résultats associés

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11497924B2 (en) 2019-08-08 2022-11-15 Realize MedTech LLC Systems and methods for enabling point of care magnetic stimulation therapy

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5116304A (en) * 1987-01-28 1992-05-26 Cadwell Industries, Inc. Magnetic stimulator with skullcap-shaped coil
US20040122281A1 (en) * 2002-12-21 2004-06-24 Neuralieve, Inc. Means and methods for treating headaches
US20050261542A1 (en) * 2004-05-24 2005-11-24 Riehl Mark E Seizure therapy method and apparatus
US20060047316A1 (en) * 2004-08-31 2006-03-02 Fischell Robert E System for the treatment of migraine headaches
US20060205993A1 (en) * 2000-08-31 2006-09-14 Fischell David R Low frequency magnetic neurostimulator for the treatment of neurological disorders

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5116304A (en) * 1987-01-28 1992-05-26 Cadwell Industries, Inc. Magnetic stimulator with skullcap-shaped coil
US20060205993A1 (en) * 2000-08-31 2006-09-14 Fischell David R Low frequency magnetic neurostimulator for the treatment of neurological disorders
US20040122281A1 (en) * 2002-12-21 2004-06-24 Neuralieve, Inc. Means and methods for treating headaches
US20050261542A1 (en) * 2004-05-24 2005-11-24 Riehl Mark E Seizure therapy method and apparatus
US20060047316A1 (en) * 2004-08-31 2006-03-02 Fischell Robert E System for the treatment of migraine headaches

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2373369A1 (fr) * 2008-11-21 2011-10-12 Burkhard Brocke Dispositif mobile d autostimulation transcrânienne et procédé de commande et de régulation du dispositif
EP2403586A4 (fr) * 2009-03-06 2017-04-26 Neuralieve, Inc. Procédé et appareil d'enregistrement et d'analyse pour traitements par tms et résultats associés
US8911342B2 (en) 2009-06-22 2014-12-16 Re5 Aps Apparatus and method for pulsed electrical field treatment

Also Published As

Publication number Publication date
ATE454923T1 (de) 2010-01-15
EP1977787B1 (fr) 2010-01-13
ES2338379T3 (es) 2010-05-06
DE602007004301D1 (de) 2010-03-04

Similar Documents

Publication Publication Date Title
US8740765B1 (en) Magnetic pulsing system for inducing electric currents in a human body
US9968798B2 (en) Transcranial magnetic stimulation device with body proximity sensors for the treatment of migraine headaches
US9561384B1 (en) Transcranial magnetic stimulation device for the treatment of migraine headaches
RU2686950C1 (ru) Системы и способы предоставления неинвазивной нейрореабилитации пациента
US20210370051A1 (en) Nasal stimulation for rhinitis, nasal congestion, and ocular allergies
US9089719B2 (en) Non-invasive methods and devices for inducing euphoria in a patient and their therapeutic application
US9526912B1 (en) Transcranial magnetic stimulation device for the treatment of migraine headaches
US7494458B2 (en) Means and methods for treating headaches
US6402678B1 (en) Means and method for the treatment of migraine headaches
US20120109251A1 (en) Transcranial electrostimulation device
US9750933B2 (en) Transcutaneous neural stimulation device
EP1977787B1 (fr) Système d'impulsion magnétique pour induire les courants électriques dans un corps humain
WO1997047352A1 (fr) Stimulateur electrique et procede pour le traitement des assuetudes
BRPI0701434B1 (pt) Sistema de pulsador magnético portátil para o tratamento de enxaquecas de um paciente humano
US20110213194A1 (en) Means and method for applying magnetic pulses to prevent the occurrence of neurological disorders
AU2021203016B2 (en) Vagus nerve stimulation system
US20060047316A1 (en) System for the treatment of migraine headaches
JP2008237692A (ja) 人体に電流を誘起する磁気パルスシステム
WO2012173618A1 (fr) Moyen et procédé pour appliquer des impulsions magnétiques pour empêcher la survenue de troubles neurologiques
CA2582608C (fr) Systeme magnetique pulse permettant d'induire des courants electriques dans un corps humain
AU2007201471B2 (en) Magnetic pulsing system for inducing electric currents in the human body
JP7423531B2 (ja) 射精のコントロール
US20160117452A1 (en) Systems and methods for prescriptions for noninvasive electrical brain stimulation
Howard et al. A clinical approach to neuromuscular electrical stimulation for speech and swallow in an acute rehabilitation facility
Burgess Magnetic Stimulators

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

17P Request for examination filed

Effective date: 20090106

17Q First examination report despatched

Effective date: 20090213

AKX Designation fees paid

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REF Corresponds to:

Ref document number: 602007004301

Country of ref document: DE

Date of ref document: 20100304

Kind code of ref document: P

RAP2 Party data changed (patent owner data changed or rights of a patent transferred)

Owner name: NEURALIEVE, INC.

REG Reference to a national code

Ref country code: NL

Ref legal event code: VDEP

Effective date: 20100113

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2338379

Country of ref document: ES

Kind code of ref document: T3

LTIE Lt: invalidation of european patent or patent extension

Effective date: 20100113

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100113

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100113

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100513

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100113

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100513

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100113

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100113

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100113

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100113

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100113

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100113

Ref country code: BE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100113

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100113

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100414

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100113

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100413

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100113

Ref country code: MC

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20100430

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100113

26N No opposition filed

Effective date: 20101014

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100113

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20100402

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100113

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20110430

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20110430

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20100402

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100714

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100113

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 9

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 10

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 11

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 12

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IE

Payment date: 20200429

Year of fee payment: 14

Ref country code: FR

Payment date: 20200427

Year of fee payment: 14

Ref country code: ES

Payment date: 20200515

Year of fee payment: 14

Ref country code: DE

Payment date: 20200430

Year of fee payment: 14

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20200424

Year of fee payment: 14

Ref country code: GB

Payment date: 20200423

Year of fee payment: 14

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 602007004301

Country of ref document: DE

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20210402

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210430

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210402

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20211103

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210402

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 20220629

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210403

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210430